A Single and Multiple Ascending Dose Study to Investigate the Safety, Tolerability, and Pharmacokinetics of AZD8965 in Healthy Participants (Including Japanese and Chinese Participants) and an Open-label Cohort to Assess the Effect of Food on the Pharmacokinetics of AZD8965 in Healthy Participants

PHASE1RecruitingINTERVENTIONAL

Enrollment

163

Participants

Timeline

Start Date

August 2, 2024

Primary Completion Date

November 10, 2025

Study Completion Date

November 10, 2025

Conditions

Healthy Participants

Interventions

DRUG

AZD8965

AZD8965 will be administered orally.

OTHER

Placebo

Placebo will be administered orally.

Trial Locations (1)

RECRUITING

Research Site, Glendale